Showing results (621-630 of 655) with videos related to
Sort By:
Pageof 66
European Journal of Clinical Investigation|April 24, 2012
Implementation of proteomic biomarkers: making it workHarald Mischak, John P A Ioannidis, Angel Argiles, et al.Diabetes Care|June 13, 2019
Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline DataMaryam Afkarian, Sarit Polsky, Afshin Parsa, et al.The Lancet. Diabetes & Endocrinology|March 6, 2020
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trialNete Tofte, Morten Lindhardt, Katarina Adamova, et al.Journal of Diabetes and Its Complications|February 25, 2023
Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria - A post-hoc analysis of the PRIORITY randomized clinical trialViktor Rotbain Curovic, Nete Tofte, Morten Lindhardt, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 31, 2020
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristicsDavid C Wheeler, Bergur V Stefansson, Mikhail Batiushin, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 5, 2014
Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathyJustyna Siwy, Joost P Schanstra, Angel Argiles, et al.Diabetes|August 11, 2021
Distinct Molecular Signatures of Clinical Clusters in People With Type 2 Diabetes: An IMI-RHAPSODY StudyRoderick C Slieker, Louise A Donnelly, Hugo Fitipaldi, et al.Hypertension (Dallas, Tex. : 1979)|February 15, 2021
Data Sharing Under the General Data Protection Regulation: Time to Harmonize Law and Research Ethics?Antonia Vlahou, Dara Hallinan, Rolf Apweiler, et al.Journal of the American Society of Nephrology : JASN|July 15, 2021
Association of Coding Variants in Hydroxysteroid 17-beta Dehydrogenase 14 (HSD17B14) with Reduced Progression to End Stage Kidney Disease in Type 1 DiabetesJosyf C Mychaleckyj, Erkka Valo, Takaharu Ichimura, et al.Matrix Biology : Journal of the International Society for Matrix Biology|June 13, 2024
The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseasesFederica Genovese, Cecilie Bager, Peder Frederiksen, et al.Pageof 66